Inhibikase Therapeutics shares owned by Saturn V Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Saturn V Capital Management
from 13F filings
Historical chart of Saturn V Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Saturn V Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $7.9M | 3.9M | 2.05 |
More positions owned by Saturn V Capital Management
View all positions for Saturn V Capital Management